Stock listing
NASDAQ:EWTX Edgewise Therapeutics, Inc. Stock
Home listing (NASDAQ) of Edgewise Therapeutics, Inc.
Follow Edgewise Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:EWTX
$38.11 USD -0.79 (-2.0%)
Close on Nov 2, 2026
- Day range
- $37.46 – $39.71 USDNov 2, 2026
- Volume
- 1.08M sharesNov 2, 2026
- Market cap
- $4.14B USDAt the close on Nov 2, 2026 · price × 108.6M shares outstanding
- 52-week range
- $16.70 – $48.51 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $60.64M USDMedian day 1.34M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EWTX · Home | $38.11 USD | -0.79 (-2.0%) | 1,083,615 | $38.93 | $39.71 | $37.46 | $38.90 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:EWTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $38.11 | -0.79 | -2.0% | $38.93 | $39.71 | $37.46 | 1,083,615 | |
| $38.90 | -0.01 | 0.0% | $38.72 | $39.44 | $38.02 | 967,477 | |
| $38.91 | -1.58 | -3.9% | $40.59 | $41.60 | $38.64 | 1,209,604 | |
| $40.49 | +0.96 | +2.4% | $39.53 | $40.56 | $38.96 | 1,629,145 | |
| $39.53 | +0.36 | +0.9% | $39.51 | $40.33 | $39.03 | 691,740 | |
| $39.17 | -0.14 | -0.4% | $39.49 | $40.44 | $38.70 | 1,009,168 | |
| $39.31 | -0.68 | -1.7% | $39.91 | $39.91 | $38.91 | 911,110 | |
| $39.99 | +0.34 | +0.9% | $39.11 | $40.69 | $38.36 | 1,337,725 | |
| $39.65 | -0.10 | -0.3% | $39.95 | $40.78 | $39.45 | 1,828,373 | |
| $39.75 | +1.83 | +4.8% | $38.03 | $40.32 | $37.88 | 2,171,190 | |
| $37.92 | +0.73 | +2.0% | $37.41 | $38.25 | $36.54 | 1,421,580 | |
| $37.19 | -1.01 | -2.6% | $38.28 | $38.28 | $36.70 | 1,305,500 | |
| $38.20 | +1.18 | +3.2% | $37.62 | $38.53 | $37.24 | 1,837,400 | |
| $37.02 | +0.74 | +2.0% | $35.93 | $37.94 | $35.63 | 1,446,100 | |
| $36.28 | -2.17 | -5.6% | $38.17 | $38.35 | $36.08 | 810,100 | |
| $38.45 | -0.61 | -1.6% | $39.12 | $39.36 | $38.32 | 1,536,600 | |
| $39.06 | -0.17 | -0.4% | $39.30 | $40.41 | $38.93 | 1,062,700 | |
| $39.23 | -0.34 | -0.9% | $38.14 | $39.41 | $37.24 | 1,363,500 | |
| $39.57 | -0.45 | -1.1% | $39.66 | $41.06 | $39.40 | 1,446,000 | |
| $40.02 | -0.28 | -0.7% | $40.66 | $41.03 | $39.34 | 1,624,900 | |
| $40.30 | -1.10 | -2.7% | $41.55 | $41.79 | $39.98 | 1,633,800 | |
| $41.40 | +0.92 | +2.3% | $41.01 | $41.94 | $40.42 | 1,459,600 | |
| $40.48 | -0.12 | -0.3% | $40.39 | $41.46 | $39.86 | 1,286,700 | |
| $40.60 | +1.41 | +3.6% | $39.49 | $42.12 | $38.89 | 1,678,300 | |
| $39.19 | -0.60 | -1.5% | $39.53 | $39.58 | $38.51 | 1,920,000 | |
| $39.79 | +0.45 | +1.1% | $39.12 | $40.10 | $39.12 | 2,983,900 | |
| $39.34 | -1.82 | -4.4% | $41.59 | $41.99 | $38.57 | 2,487,500 | |
| $41.16 | +0.11 | +0.3% | $40.28 | $41.94 | $39.74 | 1,378,700 | |
| $41.05 | -3.46 | -7.8% | $44.41 | $44.41 | $39.82 | 2,607,000 | |
| $44.51 | -0.13 | -0.3% | $44.99 | $45.99 | $44.39 | 2,091,200 | |
| $44.64 | -0.68 | -1.5% | $45.70 | $45.98 | $44.09 | 1,178,400 | |
| $45.32 | -1.62 | -3.5% | $46.79 | $46.93 | $45.32 | 1,991,800 | |
| $46.94 | +1.50 | +3.3% | $46.51 | $48.51 | $45.51 | 2,407,800 | |
| $45.44 | +1.81 | +4.1% | $43.37 | $45.60 | $43.37 | 1,683,800 | |
| $43.63 | -0.99 | -2.2% | $44.69 | $45.02 | $42.61 | 2,969,600 | |
| $44.62 | +0.22 | +0.5% | $43.98 | $45.70 | $43.95 | 1,104,400 | |
| $44.40 | +1.50 | +3.5% | $43.54 | $44.80 | $42.90 | 1,404,300 | |
| $42.90 | -0.49 | -1.1% | $42.82 | $43.50 | $42.35 | 788,600 | |
| $43.39 | -0.43 | -1.0% | $43.03 | $44.30 | $42.97 | 707,700 | |
| $43.82 | +0.75 | +1.7% | $42.85 | $44.92 | $42.21 | 1,286,400 | |
| $43.07 | +1.12 | +2.7% | $41.73 | $43.38 | $41.60 | 826,700 | |
| $41.95 | -0.03 | -0.1% | $42.32 | $43.00 | $41.40 | 976,800 | |
| $41.98 | -0.27 | -0.6% | $42.61 | $43.94 | $40.76 | 1,003,500 | |
| $42.25 | +0.48 | +1.1% | $41.59 | $42.64 | $40.82 | 1,040,500 | |
| $41.77 | -0.99 | -2.3% | $42.24 | $42.46 | $40.64 | 1,085,800 | |
| $42.76 | -1.43 | -3.2% | $43.84 | $44.19 | $42.72 | 739,800 | |
| $44.19 | -0.19 | -0.4% | $44.16 | $44.75 | $43.63 | 995,600 | |
| $44.38 | +0.17 | +0.4% | $44.21 | $45.05 | $42.91 | 814,100 | |
| $44.21 | -0.51 | -1.1% | $45.22 | $46.32 | $44.02 | 1,149,200 | |
| $44.72 | +0.54 | +1.2% | $43.67 | $45.44 | $42.59 | 1,042,000 | |
| $44.18 | +0.89 | +2.1% | $43.54 | $44.68 | $43.00 | 1,249,600 | |
| $43.29 | -3.15 | -6.8% | $45.91 | $45.91 | $43.08 | 1,338,600 | |
| $46.44 | +2.33 | +5.3% | $45.55 | $46.59 | $44.66 | 2,237,400 | |
| $44.11 | +0.07 | +0.2% | $43.17 | $45.29 | $42.62 | 1,519,200 | |
| $44.04 | -0.13 | -0.3% | $43.78 | $44.39 | $42.59 | 798,400 | |
| $44.17 | +0.99 | +2.3% | $42.75 | $44.24 | $41.98 | 779,900 | |
| $43.18 | -0.38 | -0.9% | $44.14 | $44.14 | $42.94 | 854,200 | |
| $43.56 | -0.75 | -1.7% | $44.49 | $44.75 | $43.22 | 995,800 | |
| $44.31 | -0.27 | -0.6% | $44.74 | $45.75 | $43.73 | 1,088,177 | |
| $44.58 | +1.06 | +2.4% | $43.71 | $44.88 | $42.50 | 2,018,084 | |
| $43.52 | -0.90 | -2.0% | $44.00 | $44.20 | $42.46 | 1,478,300 | |
| $44.42 | -0.57 | -1.3% | $44.13 | $45.53 | $43.56 | 1,451,100 | |
| $44.99 | +0.285 | +0.6% | $44.85 | $45.93 | $44.37 | 1,734,400 | |
| $44.71 | +6.325 | +16.5% | $41.00 | $45.44 | $41.00 | 4,187,500 | |
| $38.38 | -0.05 | -0.1% | $38.15 | $38.77 | $36.88 | 771,600 |
- Ticker
- NASDAQ:EWTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 8, 2026
Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400
Latest deck · October 2026
Technical Presentation (October 2026)
Technical · 6 slides
Latest news
Edgewise Therapeutics Doses First Patient in Phase 2 EQUINOX-HFpEF Trial of EDG-15400
Oct 8, 2026
Closed $39.23 (-0.9%) on Oct 8, 2026
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Oct 1, 2026
Closed $40.48 (-0.3%) on Oct 1, 2026
Edgewise Therapeutics Unveils the Differentiated Mechanism of Action (MoA) of its Cardiac Sarcomere Modulator EDG-7500
Sep 22, 2026
Closed $44.51 (-0.3%) on Sep 22, 2026
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
Aug 24, 2026
Closed $44.72 (+1.2%) on Aug 24, 2026
Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
Jul 13, 2026
Closed $41.27 (-9.1%) on Jul 13, 2026
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
Jul 13, 2026
Closed $41.27 (-9.1%) on Jul 13, 2026
Edgewise Therapeutics Announces Positive Top-Line Data from 12-Week Phase 2 CIRRUS-HCM Trial with EDG-7500 in Obstructive and Nonobstructive Hypertrophic Cardiomyopathy (HCM)
Jun 16, 2026
Closed $33.95 (-3.6%) on Jun 16, 2026
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
Jun 1, 2026
Closed $40.26 (+17.9%) on Jun 1, 2026
Decks
Technical Presentation (October 2026)
Technical · 6 slides · October 2026
Technical Presentation (September 2026)
Technical · 42 slides · Sep 22, 2026
Technical Presentation (August 2026)
Technical · 25 slides · August 2026
World Muscle Society Conference 2025 Symposium
Conference · 55 slides · Oct 8, 2025
Edgewise Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 120 in all · newest Oct 8, 2026 · oldest 2021
- Decks
- 18 decks · latest October 2026
Where Edgewise Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EWTX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:EWTX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Edgewise Therapeutics, Inc.